Oseltamivir Phosphate Patent Expiration
Oseltamivir Phosphate is Used for preventing and treating influenza infections. It was first introduced by Hoffmann La Roche Inc
Oseltamivir Phosphate Patents
Given below is the list of patents protecting Oseltamivir Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tamiflu |
US5763483 (Pediatric) | Carbocyclic compounds |
Jun 27, 2017
(Expired) | Roche |
| Tamiflu | US5763483 | Carbocyclic compounds |
Dec 27, 2016
(Expired) | Roche |
| Tamiflu |
US5866601 (Pediatric) | Carbocyclic compounds |
Aug 02, 2016
(Expired) | Roche |
| Tamiflu | US5866601 | Carbocyclic compounds |
Feb 02, 2016
(Expired) | Roche |
| Tamiflu |
US5952375 (Pediatric) | Compounds and methods for synthesis and therapy |
Aug 27, 2015
(Expired) | Roche |
| Tamiflu | US5952375 | Compounds and methods for synthesis and therapy |
Feb 27, 2015
(Expired) | Roche |
Oseltamivir Phosphate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List